Skip to main content
Top
Metadata
Title
Risk factors for the development of adverse drug events in hospitalized patients
Authors
P.M.L.A. van den Bemt
A.C.G. Egberts
A.W. Lenderink
J.M. Verzijl
K.A. Simons
W.S.C.J.M. van der Pol
H.G.M. Leufkens
Publication date
01-04-2000
Publisher
Kluwer Academic Publishers
Published in
International Journal of Clinical Pharmacy / Issue 2/2000
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1023/A:1008721321016

Other articles of this Issue 2/2000

International Journal of Clinical Pharmacy 2/2000 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.